Atıf Formatları
Vertebral fracture risk in patients with differentiated thyroid cancer receiving TSH-suppressive therapy
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

D. YAVUZ Et Al. , "Vertebral fracture risk in patients with differentiated thyroid cancer receiving TSH-suppressive therapy," ENDOCRINE CONNECTIONS , vol.15, no.7, 2026

YAVUZ, D. Et Al. 2026. Vertebral fracture risk in patients with differentiated thyroid cancer receiving TSH-suppressive therapy. ENDOCRINE CONNECTIONS , vol.15, no.7 .

YAVUZ, D., Dincer Yazan, C., HEKİMSOY, Z., Aydin, K., Gokkaya, N., ERSOY, C., ... Aydogan, B. I.(2026). Vertebral fracture risk in patients with differentiated thyroid cancer receiving TSH-suppressive therapy. ENDOCRINE CONNECTIONS , vol.15, no.7.

YAVUZ, DİLEK Et Al. "Vertebral fracture risk in patients with differentiated thyroid cancer receiving TSH-suppressive therapy," ENDOCRINE CONNECTIONS , vol.15, no.7, 2026

YAVUZ, DİLEK Et Al. "Vertebral fracture risk in patients with differentiated thyroid cancer receiving TSH-suppressive therapy." ENDOCRINE CONNECTIONS , vol.15, no.7, 2026

YAVUZ, D. Et Al. (2026) . "Vertebral fracture risk in patients with differentiated thyroid cancer receiving TSH-suppressive therapy." ENDOCRINE CONNECTIONS , vol.15, no.7.

@article{article, author={DİLEK YAVUZ Et Al. }, title={Vertebral fracture risk in patients with differentiated thyroid cancer receiving TSH-suppressive therapy}, journal={ENDOCRINE CONNECTIONS}, year=2026}